NORTH STAR ASSET MANAGEMENT INC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTH STAR ASSET MANAGEMENT INC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$618,710
+10.6%
13,6400.0%0.04%
+16.1%
Q2 2023$559,649
+14.5%
13,640
-0.3%
0.03%
+6.9%
Q1 2023$488,923
-5.4%
13,6800.0%0.03%
-9.4%
Q4 2022$516,694
-14.6%
13,6800.0%0.03%
-22.0%
Q3 2022$605,000
+19.6%
13,6800.0%0.04%
+24.2%
Q2 2022$506,000
-0.2%
13,6800.0%0.03%
+17.9%
Q1 2022$507,000
+21.9%
13,6800.0%0.03%
+33.3%
Q4 2021$416,000
-9.4%
13,6800.0%0.02%
-16.0%
Q3 2021$459,000
-16.4%
13,680
-0.5%
0.02%
-16.7%
Q2 2021$549,000
-11.2%
13,7530.0%0.03%
-18.9%
Q1 2021$618,000
-20.7%
13,753
-0.1%
0.04%
-24.5%
Q4 2020$779,000
+19.1%
13,7730.0%0.05%
+2.1%
Q3 2020$654,000
-19.1%
13,773
+0.5%
0.05%
-25.0%
Q2 2020$808,000
+24.7%
13,7000.0%0.06%
+1.6%
Q1 2020$648,000
-29.4%
13,700
-9.9%
0.06%
-4.5%
Q4 2019$918,000
+0.8%
15,2000.0%0.07%
-7.0%
Q3 2019$911,000
-6.8%
15,2000.0%0.07%
-6.6%
Q2 2019$977,000
-20.8%
15,2000.0%0.08%
-24.0%
Q1 2019$1,234,000
+50.1%
15,2000.0%0.10%
+28.2%
Q4 2018$822,000
+4.8%
15,2000.0%0.08%
+23.8%
Q3 2018$784,000
+23.9%
15,2000.0%0.06%
+16.7%
Q2 2018$633,000
-5.5%
15,2000.0%0.05%
-10.0%
Q1 2018$670,000
-12.4%
15,2000.0%0.06%
-13.0%
Q4 2017$765,00015,2000.07%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders